- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02525809
Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis. (DOUMOB)
The total hip replacement, with over 120,000 cases per year in France, provides short term, excellent functional results and a significant improvement in quality of life, in almost all cases. However, observation showed that the dislocation is not a rare complication (2-4%) and the lifetime of the implants is limited due to aseptic loosening.
The evaluation process used in this study will be the extent of penetration of the metal femoral head in the cup and micro mobility metal back by radiostereometric analysis (RSA) whose precision provides early results (2 3 years), long before wear and migration are measurable by conventional radiological means. The main objective will be to compare, 2 years after the intervention, the penetration of the metal femoral head in 3 types of inserts: two dual mobility inserts, one at tripod attachment (Novae E®), the other press fit pure (Sunfit®), and a fixed insert (Quartz®).
This is a randomized controlled trial. 105 patients will be enrolled (35 in each group). Patients will be included in each of the two participating centers (Amiens, Caen). The analysis will be made in RSA D7 + 2, 6 months 1, 12 months 1 24 months 1. An assessment will be made to 3 years if the analysis requires it to 2 years.
Analysis of pictures will be centralized in Caen and performed with specific software after transferring images via a secure network.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients older men or women 60-75 years
- with a primary or secondary osteoarthritis or osteonecrosis
- having a functional disorder requiring the installation of a total hip prosthesis of primary
Exclusion Criteria:
- patients aged 76 years or more
- protected adults
- resumption of PTH
- cephalic prosthesis recovery or intermediate
- resumption of cupules
- primary or secondary malignant tumor of the hip
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: mobility insert with tripod attachment (Novae E®)
|
|
Other: mobility insert with press fit pure (Sunfit®)
|
|
Other: fixed insert (Quartz®).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Measuring the penetration of the femoral head in the polyethylene inserts by radiostereometric analysis (RSA)
Time Frame: change over baseline and 3 years
|
change over baseline and 3 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 08-114
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Replacement
-
National Taiwan University HospitalUnknownTotal Hip Replacement | Total Hip ArthroplastyTaiwan
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical AssociationCompletedTotal Hip Replacement | Total Knee ReplacementCanada
-
The Royal Bournemouth HospitalCompletedArthroplasty, Replacement, Hip | Hip Replacement, TotalUnited Kingdom
-
Ortho Development CorporationOregon Health and Science UniversityEnrolling by invitationTotal Hip Replacement | Total Hip ArthroplastyUnited States
-
Mayo ClinicCompletedKnee Total Joint Replacement | Hip Total Joint ReplacementUnited States
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
-
Schulthess KlinikNot yet recruitingTotal Hip Replacement
-
Koneksa HealthRecruitingTotal Hip ReplacementUnited States
-
Second Hospital of Shanxi Medical UniversityRecruitingTotal Hip ReplacementChina
-
Medacta International SASuspended
Clinical Trials on Novae E®
-
CHU de ReimsRecruitingIntermittent ClaudicationFrance
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompleted
-
Fresenius KabiTerminatedCancer-related MalnutritionFrance
-
Implantcast North America, LLCNot yet recruitingFemoral Fracture | Osteoarthritis, Hip | Traumatic Arthritis | Degenerative Joint Disease
-
Jun ZhangXiamen Innovax Biotech Co., Ltd; Xiamen Center for Disease Control and PreventionCompleted
-
Keimyung University Dongsan Medical CenterCompletedConstipationKorea, Republic of
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Systemic Lupus ErythematosusUnited States
-
Gilead SciencesCompletedHIV Infections | HIVUnited States, United Kingdom, Sweden, France, Puerto Rico, Netherlands, Italy, Portugal, Canada, Mexico, Dominican Republic
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan